P. Brent Ferrell, Jr., M.D.Assistant Professor
Earl DC, Ferrell PB Jr., Leelatian N, Froese JT, Reisman BJ, Irish JM, Bachmann BO. Discovery of human cell selective effector molecules using single cell multiplexed activity metabolomics. Nat Comm. c2018 Jan 1/2/2018; 9(1): 39. PMID: 29295987.
Roussel M, Ferrell PB, Greenplate AR, Lhomme F, Le Gallou S, Diggins KE, Johnson DB, Irish JM. Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow. J. Leukoc. Biol [print-electronic]. 2017 Apr 4/11/2017; PMID: 28400539, PII: jlb.5MA1116-457R, DOI: 10.1189/jlb.5MA1116-457R, ISSN: 1938-3673.
Greenplate AR, Johnson DB, Ferrell PB, Irish JM. Systems immune monitoring in cancer therapy. Eur. J. Cancer [print-electronic]. 2016 Jul; 61: 77-84. PMID: 27155446, PMCID: PMC4885747, PII: S0959-8049(16)32047-0, DOI: 10.1016/j.ejca.2016.03.085, ISSN: 1879-0852.
Greenplate AR, Johnson DB, Roussel M, Savona MR, Sosman JA, Puzanov I, Ferrell PB, Irish JM. Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti-PD-1 Therapy. Cancer Immunol Res [print-electronic]. 2016 Jun; 4(6): 474-80. PMID: 26966176, PMCID: PMC4891280, PII: 2326-6066.CIR-15-0213, DOI: 10.1158/2326-6066.CIR-15-0213, ISSN: 2326-6074.
Ferrell PB, Diggins KE, Polikowsky HG, Mohan SR, Seegmiller AC, Irish JM. High-Dimensional Analysis of Acute Myeloid Leukemia Reveals Phenotypic Changes in Persistent Cells during Induction Therapy. PLoS ONE. 2016; 11(4): e0153207. PMID: 27074138, PMCID: PMC4830605, PII: PONE-D-15-20447, DOI: 10.1371/journal.pone.0153207, ISSN: 1932-6203.
Diggins KE, Ferrell PB, Irish JM. Methods for discovery and characterization of cell subsets in high dimensional mass cytometry data. Methods [print-electronic]. 2015 Jul 7/1/2015; 82: 55-63. PMID: 25979346, PMCID: PMC4468028, PII: S1046-2023(15)00199-1, DOI: 10.1016/j.ymeth.2015.05.008, ISSN: 1095-9130.
Ferrell PB, McLeod HL. Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics. 2008 Oct; 9(10): 1543-6. PMID: 18855540, PMCID: PMC2586963, DOI: 10.2217/146224184.108.40.2063, ISSN: 1744-8042.
Postdoctoral opportunities in Leukemia and Bone Marrow Inflammation:
Position: The Ferrell Lab (https://medsites.mc.vanderbilt.edu/ferrelllab) is seeking a highly skilled, motivated and energetic post-doctoral fellow to conduct disease-focused research in myelodysplastic syndromes, acute myeloid leukemia and bone marrow immunology/inflammation. The position comes with competitive salary and excellent potential for career development.
Requirements: Qualified candidates should have strong fund of knowledge in cancer biology and/or immunology and have experience in several (but not all) of the following areas: single cell experimentation and data analysis (e.g., RNAseq, CyTOF), computational biology (including experience with R), in vitro immunology assays, and xenograft models of primary human leukemia. The qualified applicant should have a doctoral degree in biomedical science (PhD or MD/PhD), a strong publication record (primary peer-reviewed publications) and excellent writing/communication skills. Successful applicants will have opportunity to tailor project related to above to individual interests and skills.
Environment: Candidates will receive focused and personalized mentoring from the PI, the Division of Hematology/Oncology, and the School of Medicine. Vanderbilt University Medical Center is a large, collaborative environment for biomedical research with many opportunities for career development, funding, and education for postdoctoral researchers. Our lab is a member of the renowned Vanderbilt-Ingram Cancer Center, which brings together clinicians, basic scientists, engineers and statisticians in close collaboration due to its interdisciplinary research and close physical proximity. The PI also conducts early phase clinical trials for AML and MDS which serve as a source of patient samples and collaborative studies.
Interested applicants should contact the PI at: brent.ferrell at vumc.org.